826 / 1840
Long term Quality of life
•
42 patients contacted: 51% answered
•
Age at treatment: 1.7 (0-16) years
•
Median FU: 15 years
•
90%: good or very good QoL
•
Dichotomy before and after 1990
•
No endocrine disorder or puberty delay
•
1 second malignancy (uterine sarcoma)
•
Late Side effect mainly urologic and gynecologic
•
28% had grade 3-4 events